AlphaThera has been recognized in the CiteAb 2026 Researchers’ Choice Award, recognizing reagent suppliers that have made a meaningful impact on the global research community.
The award is based on nominations from researchers, highlighting suppliers that consistently deliver exceptional quality, service, and support. AlphaThera was recognized by its customers for its reliability, responsiveness, and commitment to meeting specific research needs.
One researcher commented:
“They have been incredibly reliable, communicative, and accessible. They went above and beyond to provide us technical support on our request antibodies and even customized orders to meet our needs.”
Dr Andrew Tsourkas, Co-Founder of AlphaThera, said:
“We are delighted to have been recognized in the CiteAb Researchers’ Choice Award. We are committed to delivering high-quality products alongside outstanding customer support, and it is incredibly rewarding to see this reflected in feedback from our customers. As a growing company, we are very proud of what we have achieved.”
